CLINICAL AND SCIENTIFIC ASSESSMENT

Efficacy and safety alone will no longer drive success in the life sciences industry. Clinical differentiation and demonstrated outcomes are the new imperatives. Product development lead times require a mid- to long-term perspective to characterize the competitive market landscape.

Kantar Health’s clinical and scientific assessment experts provide data and insights to successfully move your product through the clinical trial process and into the market. Our team has deep clinical and commercial expertise to support your most important business decisions.

Clinical and scientific assessment services:
  • Pipeline prioritization and portfolio planning
  • Assessment of merits of new compounds in development
  • Standard-of-care analysis and emerging treatment trends
  • Scientific meeting coverage
  • Identifying, validating and advising on in-/out-licensing opportunities
  • Providing input on clinical trial design to maximize market access

CONTACT US TODAY TO GET STARTED.

Kantar Health provides consulting and research to communicate the value and potential for products and services that fall under healthcare regulation and legislation.

LET'S TALK

Complete the form below and a representative will follow up with you.
By submitting this form you are opting-in to communications from Kantar Health and agree to our terms & conditions and privacy policy.